For years, Spirulina has been marketed as a nutritional powerhouse, a vibrant green “superfood” capable of filling the gaps in a modern diet. But for the millions of people relying on it to prevent Vitamin B12 deficiency—particularly those following plant-based diets—the promise was largely an illusion.
The problem lies in a biochemical trick. While standard Spirulina contains B12-like compounds, they are primarily “pseudo-B12,” a form that looks like the vitamin but is biologically inactive in the human body. In some cases, these analogues can even interfere with the absorption of real B12, potentially masking a deficiency until it reaches a critical stage.
Now, a multi-national team of researchers has found a way to flip the switch. By manipulating the environment in which the algae grows, they have produced a version of Spirulina that yields bioavailable, active Vitamin B12 in concentrations comparable to beef, offering a sustainable alternative to animal-based supplements and meat consumption.
The findings, published in the journal Discover Food, represent a potential shift in how we address one of the world’s most persistent nutritional deficits. Led by Dr. Asaf Tzachor of Reichman University, alongside collaborators from Iceland, Denmark, and Austria, the study suggests that the key to unlocking this nutrient isn’t genetic modification, but the precise application of light.
The “Pseudo-B12” Trap and the Global Deficit
Vitamin B12 is a cornerstone of human health, essential for the synthesis of DNA, the maintenance of the nervous system, and the production of red blood cells. When levels drop, the results are systemic: profound fatigue, dizziness, cognitive decline, and in severe cases, permanent nerve damage or anemia. For infants, a deficiency can lead to irreversible developmental delays.
Estimates suggest that more than one billion people worldwide suffer from some level of B12 deficiency. While the vitamin is abundant in meat, eggs, and dairy, these sources come with a heavy environmental price tag. Industrial cattle farming is a primary driver of greenhouse gas emissions, deforestation, and excessive water consumption, making the search for a non-animal source a public health and ecological priority.
Until now, the only viable plant-based options were supplements—often synthetic and expensive—or fortified foods. The discovery that Spirulina can be “trained” to produce active B12 changes the equation by providing a whole-food source that is both sustainable and biologically effective.
Hacking Algae with Light
The breakthrough centers on a method called “photosynthetically controlled Spirulina.” Rather than altering the algae’s DNA, the researchers adjusted its metabolism by controlling the light spectra it received during growth.
Using a biotechnological system developed by the Icelandic company VAXA Technologies, the team grew the algae in closed photobioreactors. These sealed systems allow for total control over the environment, shielding the algae from contaminants while optimizing the light wavelengths that trigger specific metabolic pathways.
The results were stark. In this controlled environment, more than 98% of the Vitamin B12 produced was in a form the human body can actually use. The researchers found that the B12 profile remained stable for at least nine months, proving that this isn’t a fleeting chemical reaction but a sustainable biological state.
| Source | B12 Content (approx. Per 100g) | Bioavailability | Environmental Impact |
|---|---|---|---|
| Standard Spirulina | Variable | Very Low (Pseudo-B12) | Low |
| Beef | ~1.6 – 2.0 μg | High | Very High |
| Controlled Spirulina | 1.64 μg | High (>98%) | Low |
From the Lab to the Global Table
The implications of this research extend far beyond the laboratory. The study highlighted the specific potential of Iceland as a production hub. Because Iceland possesses abundant renewable geothermal and hydroelectric energy, the energy-intensive process of powering LED photobioreactors becomes carbon-neutral.
If scaled industrially, this system could produce hundreds of thousands of tons of B12-rich Spirulina annually. For regions struggling with food insecurity and malnutrition, particularly where meat is unaffordable or culturally avoided, this could provide a low-cost, high-impact intervention to protect the neurological health of millions of children.
However, the transition from a controlled study to a global commodity will require significant infrastructure investment. The challenge now lies in moving from the photobioreactors of VAXA Technologies to a commercial scale that can compete with the pricing of synthetic supplements.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider before starting new supplements or making significant dietary changes, especially if you suspect a vitamin deficiency.
The next phase for the research team involves optimizing the growth cycles to further increase B12 yields and exploring the integration of this “controlled” algae into mass-market food products. Official updates on the scalability of the VAXA system are expected as the company seeks further industrial partnerships in Northern Europe.
Do you rely on supplements or whole foods for your B12 intake? We invite you to share your experiences and thoughts in the comments below or share this story with your network.
